Carey Smith
Founding Contrarian @ Unorthodox Ventures
Austin, United States
Carey Smith is a venture - series unknown investor at Unorthodox Ventures in Austin focused on Health Care and Medical Device. Carey Smith is the Founding Contrarian at Unorthodox Ventures. He attended Hood College.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Carey Smith invests in
Stages Carey Smith invests in
Countries Carey Smith invests in
Investment Focus
Industry
- Health Care 3 (60%)
- Medical Device 2 (40%)
- Fitness 1 (20%)
- Medical 1 (20%)
- Therapeutics 1 (20%)
Stage
- Venture - Series Unknown 2 (40%)
- Series B 1 (20%)
- Series E 1 (20%)
Country
- France 1 (20%)
- Israel 1 (20%)
- Germany 1 (20%)
- Switzerland 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CarThera
|
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reachthe brain. | $4.8M / Series B / Dec 11, 2023 | |
Zippsafe
|
Zippsafe AG is a technology company provider of highly space-efficient storage solutions. The company's core competence lies in the development, manufacture, and installation of lockable closing bags for changing rooms and for public spaces. | Venture - Series Unknown / Aug 19, 2022 | |
DiaMonTech AG
|
DiaMonTech is developing a medical device for non-invasive measurement of blood sugar values. The patented process uses laser technology to determine and control blood glucose values of diabetes patients without any pain and without drawing blood. | $5.7M / Venture - Series Unknown / Feb 17, 2022 | |
Vibrant Gastro
|
Vibrant has developed a prescribed, non-drug digital treatment platform for GI disorders, delivering stimulation to the colon, focusing on its first indication Chronic Idiopathic Constipation (CIC). Its non-drug data-driven solution for CIC helps patients obtain relief and regain quality of life, empowers physicians with tools to provide optimizedand better care, and motivates payors to adopt non-drug treatment options that lower health risks and potential comorbidities, alleviating financial burden on the healthcare system. | $7.5M / Series E / Mar 29, 2021 | |
|
Vibrant Gastro
|
Vibrant has developed a prescribed, non-drug digital treatment platform for GI disorders, delivering stimulation to the colon, focusing on its first indication Chronic Idiopathic Constipation (CIC). Its non-drug data-driven solution for CIC helps patients obtain relief and regain quality of life, empowers physicians with tools to provide optimizedand better care, and motivates payors to adopt non-drug treatment options that lower health risks and potential comorbidities, alleviating financial burden on the healthcare system. | $7.5M / Series E / Mar 26, 2021 |
Co-Investors
About Unorthodox Ventures
Unorthodox Ventures is a complete reinvention of the broken and parasitic investment process. Founded by contrarian entrepreneur Carey Smith who bootstrapped Big Ass Fans to a $500 million sale, the company is seeking to partner with founders who demonstrate disruption and discipline. Unlike most investors, Unorthodox Ventures shuns financiers andinstead is filled with people who have actually operated companies and know how to grow them.
Unorthodox Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Carey Smith
Founding Contrarian
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Carey Smith invest in?
Carey Smith invests primarily in Health Care, Medical Device and Fitness startups, most often at Venture - Series Unknown and Series B stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Carey Smith last invest?
The most recent investment recorded for Carey Smith closed in Dec 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
